209
Participants
Start Date
January 31, 2005
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Topical testosterone gel 1% (active formulation)
Starting dose 10 g/day; increased to 15 g/day or decreased to 5 g/day in order to attain morning total testosterone level between 500 - 1000 ng/dL. Blinding achieved by combining a total of 3 tubes of active or placebo gel, applied to upper arms and shoulders each day.
Topical gel (placebo formulation)
Starting dose 15 g/day (3 tubes), applied to upper arms and shoulders each day.
Boston University Medical Center, Boston
VA Boston Healthcare System (Jamaica Plain Campus), Boston
Lead Sponsor
National Institute on Aging (NIA)
NIH
Boston Medical Center
OTHER